Contec Medical Systems Co.,Ltd (SHE:300869)

SHE:300869 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	777.86	684.31	470.53	1,393	623.98	814.07
Short-Term Investments	603.6	252.03	840.82	486.27	189.98	-
Trading Asset Securities	633.33	171.59	652.02	46.64	-	-
Cash & Short-Term Investments	2,015	1,108	1,963	1,926	813.96	814.07
Cash Growth	46.29%	-43.57%	1.96%	136.57%	-0.01%	341.70%
Accounts Receivable	47.43	46	39.86	160.75	66.21	101.67
Other Receivables	9.96	7.34	7.09	13.76	39.88	4.05
Receivables	57.39	533.58	46.96	174.52	106.09	105.71
Inventory	267.77	272.32	463.23	430.24	418.69	284.42
Prepaid Expenses	-	1.21	1.78	1.42	4.08	1.37
Other Current Assets	35.57	6.18	6.83	26.64	9.31	61.62
Total Current Assets	2,376	1,921	2,482	2,558	1,352	1,267
Property, Plant & Equipment	299.77	336.07	290.76	275.13	226.09	151.14
Long-Term Investments	-	403.95	360.47	298.04	1,156	636.96
Other Intangible Assets	50.39	52.07	54.74	57.47	33.61	13.07
Long-Term Deferred Tax Assets	6.18	3.78	5.8	1.81	0.73	3.73
Long-Term Deferred Charges	0.05	0.07	-	-	-	-
Other Long-Term Assets	58.98	8.36	18	541.93	20.63	25.72
Total Assets	2,791	2,726	3,212	3,733	2,789	2,098
Accounts Payable	20.93	18.39	17.79	54.3	47.62	93.36
Accrued Expenses	12.37	12.93	15.68	32.69	15.95	17.03
Short-Term Debt	197	60	347	903.37	800.39	267.94
Current Portion of Leases	1.61	1.71	3.16	1.67	1.15	-
Current Income Taxes Payable	5.12	0.24	26.1	18.81	37.65	95.12
Current Unearned Revenue	34.11	32.04	39.97	76.6	45.61	38.57
Other Current Liabilities	4.2	9.48	10.25	25.11	7.27	2.91
Total Current Liabilities	275.35	134.79	459.94	1,113	955.64	514.92
Long-Term Debt	740.46	723.52	695.57	666.94	-	-
Long-Term Leases	1.64	1.83	2.72	4.06	2.79	-
Long-Term Unearned Revenue	7.25	7.81	8.92	9.07	9.76	11.58
Long-Term Deferred Tax Liabilities	0.05	0.15	0	11.85	0.8	2.5
Total Liabilities	1,025	868.1	1,167	1,804	968.99	529
Common Stock	401.8	401.8	401.8	401.8	401.8	401.8
Additional Paid-In Capital	352.35	352.34	345.14	344.98	344.98	344.98
Retained Earnings	979.28	1,070	1,265	1,150	1,074	822.2
Comprehensive Income & Other	32.69	32.94	32.54	31.79	-0.82	-0.15
Shareholders' Equity	1,766	1,857	2,045	1,928	1,820	1,569
Total Liabilities & Equity	2,791	2,726	3,212	3,733	2,789	2,098
Total Debt	940.72	787.07	1,048	1,576	804.33	267.94
Net Cash (Debt)	1,074	320.85	914.91	349.56	9.63	546.13
Net Cash Growth	89.07%	-64.93%	161.73%	3529.53%	-98.24%	230.13%
Net Cash Per Share	2.62	0.78	2.21	0.86	0.02	1.46
Filing Date Shares Outstanding	401.8	401.8	401.8	401.8	401.8	401.8
Total Common Shares Outstanding	401.8	401.8	401.8	401.8	401.8	401.8
Working Capital	2,100	1,786	2,022	1,446	396.5	752.27
Book Value Per Share	4.40	4.62	5.09	4.80	4.53	3.90
Tangible Book Value	1,716	1,805	1,990	1,871	1,786	1,556
Tangible Book Value Per Share	4.27	4.49	4.95	4.66	4.45	3.87
Buildings	-	245.65	226.46	232.82	142.81	142.18
Machinery	-	181.12	169.29	147.98	125.88	90.26
Construction In Progress	-	72.85	24.55	1.32	51.22	3.86

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.